Skip to main content

Vitiligo clinical trials at University of California Health

4 in progress, 3 open to eligible people

Showing trials for
  • AMG 714 for Vitiligo

    open to eligible people ages 18-75

    This study is designed to evaluate the efficacy of AMG 714 for the treatment of adult participants with vitiligo.

    at UC Davis UC Irvine

  • Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

    open to eligible people ages 18 years and up

    To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.

    at UC Davis UC Irvine

  • Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

    open to all eligible people

    TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

    at UC Irvine UCSD

  • Ruxolitinib Cream With Phototherapy in Participants With Vitiligo

    Sorry, in progress, not accepting new patients

    The purpose of this study is to evaluate the efficacy and safety of Ruxolitinib cream with or without phototherapy in adolescent and adult participants with non-segmental vitiligo for whom vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).

    at UC Davis

Our lead scientists for Vitiligo research studies include .

Last updated: